Axsome Therapeutics, Inc. (AXSM)

NASDAQ: AXSM · Real-Time Price · USD

233.64

+3.02 (1.31%)

At close: May 21, 2026, 4:00 PM EDT

235.39

+1.75 (0.75%)

After-hours: May 21, 2026, 7:50 PM EDT

Axsome Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 21, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	12,023	9,293	4,118	3,769	3,355	1,429
Market Cap Growth	117.71%	125.69%	9.26%	12.33%	134.83%	-53.08%
Enterprise Value	11,938	9,185	3,992	3,568	3,248	1,391
Last Close Price	233.64	182.64	84.61	79.59	77.13	37.78
PS Ratio	16.98	14.55	10.68	13.93	67.05	-
PB Ratio	220.09	105.25	72.22	19.73	30.62	91.41
P/TBV Ratio	215.39	102.90	71.10	18.93	28.62	90.93
EV/Sales Ratio	16.86	14.39	10.35	13.18	64.92	-
Debt / Equity Ratio	3.96	2.44	3.33	0.97	0.86	3.14
Net Debt / Equity Ratio	-1.62	-1.22	-2.17	-1.05	-0.97	-2.35
Net Debt / EBITDA Ratio	0.54	0.68	0.45	0.89	0.61	0.30
Net Debt / FCF Ratio	1.25	1.14	0.96	1.37	0.91	0.34
Asset Turnover	1.01	1.01	0.67	0.59	0.24	0
Inventory Turnover	1.76	2.17	2.16	2.68	2.41	-
Quick Ratio	1.27	1.44	1.99	3.46	2.47	3.75
Current Ratio	1.39	1.55	2.11	3.63	2.54	3.75
Return on Equity (ROE)	-263.58%	-252.12%	-231.63%	-159.21%	-298.97%	-201.51%
Return on Assets (ROA)	-24.60%	-26.43%	-48.52%	-50.62%	-85.77%	-91.05%
Return on Invested Capital (ROIC)	-288.83%	-327.19%	-539.58%	-418.40%	-1866.52%	606.97%
Return on Capital Employed (ROCE)	-59.16%	-51.36%	-71.23%	-67.76%	-120.01%	-109.67%
Buyback Yield / Dilution	-4.24%	-3.83%	-5.48%	-11.73%	-8.07%	-1.11%
Total Shareholder Return	-4.24%	-3.83%	-5.48%	-11.73%	-8.07%	-1.11%

Updated May 4, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q